JAMA Oncology/X
Jun 16, 2026, 15:26
JAMA Oncology: Avelumab Plus Methotrexate in Gestational Trophoblastic Tumors
JAMA Oncology shared a post on X about a paper by Benoit You et al. published in JAMA Oncology:
“Avelumab combined with methotrexate resulted in >95% durable remission and preserved fertility in low-risk gestational trophoblastic tumors, with a manageable safety profile.”
Title: Avelumab Plus Methotrexate for Gestational Trophoblastic Tumors
Authors: Benoit You, Jean-Pierre Lotz, Pierre Descargues
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 3, 2026, 17:32Kathiuska Kriedt: What the National Fertility Awareness Week Means to Me
-
Nov 3, 2026, 17:31Saff Mitten: Grieving the Person You Were Before Infertility and IVF
-
Nov 3, 2026, 17:29Rajeev Agarwal: All Reports Normal, Still Not Pregnant?
-
Nov 3, 2026, 17:27When It Comes to RPL, More Treatment Does Not Always Mean Better Care – ESHRE SIG Reproductive Genetics
-
Nov 3, 2026, 17:24Eva van Rooijen: As A Mother Thanks to IVF, I Used to Think I Understood the Struggle…
-
Nov 3, 2026, 17:22What Would Work Look Like If People Didn’t Have to Choose Between Their Fertility Journey and Their Job? – ESHRE
-
Nov 3, 2026, 17:19Expert Fertility Care, Closer to Home in Salisbury – Complete Fertility
-
Nov 3, 2026, 17:15Alexander Nadal: Still Processing ASRM 2026
-
Nov 3, 2026, 17:12Beatrice Chemla: ASRM INNOVATE 2026 – A Remarkable Toolkit for Building the Future of IVF